Altium Wealth Management LLC Hutchmed (China) LTD Transaction History

Altium Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$15.52 - $35.65 $243,105 - $558,421	-15,664 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$28.89 - $35.33 $34,407 - $42,078	-1,191 Reduced 7.07%	15,664 $549,000
Q2 2021 Aug 13, 2021	SELL	$23.7 - $39.27 $112,432 - $186,296	-4,744 Reduced 21.96%	16,855 $662,000
Q1 2021 May 06, 2021	SELL	$27.01 - $36.8 $22,607 - $30,801	-837 Reduced 3.73%	21,599 $610,000
Q4 2020 Feb 04, 2021	SELL	$27.51 - $34.36 $11,691 - $14,603	-425 Reduced 1.86%	22,436 $718,000

Q3 2020 Oct 26, 2020	SELL	$25.8 - $34.61 $278,511 - $373,614	-10,795 Reduced 32.07%	22,861 $738,000
Q2 2020 Jul 31, 2020	BUY	$17.65 - $28.05 $243,958 - $387,707	13,822 Added 69.69%	33,656 $928,000
Q1 2020 Apr 23, 2020	BUY	$15.19 - $29.51 $301,278 - $585,301	19,834 New	19,834 $354,000

14M

2.7K

3.7K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.03B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Altium Wealth Management LLC with notifications on news.